Equities Analysts Offer Predictions for STERIS plc’s Q4 2024 Earnings (NYSE:STE)

STERIS plc (NYSE:STE) – Equities researchers at Zacks Research dropped their Q4 2024 earnings estimates for STERIS in a research note issued on Thursday, May 2nd. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings per share of $2.41 for the quarter, down from their prior forecast of $2.42. The consensus estimate for STERIS’s current full-year earnings is $8.67 per share. Zacks Research also issued estimates for STERIS’s Q1 2025 earnings at $2.16 EPS and Q2 2026 earnings at $2.55 EPS.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.05. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The company’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter last year, the business posted $2.02 EPS.

A number of other analysts also recently issued reports on STE. StockNews.com downgraded shares of STERIS from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, April 12th. KeyCorp assumed coverage on STERIS in a report on Tuesday, February 6th. They set an “overweight” rating and a $253.00 target price on the stock. Finally, JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 8th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $239.60.

STERIS Stock Up 1.6 %

NYSE:STE opened at $212.87 on Monday. The company has a market cap of $21.03 billion, a PE ratio of 37.28 and a beta of 0.81. The stock has a 50-day simple moving average of $217.58 and a 200 day simple moving average of $216.01. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. STERIS has a 52-week low of $185.22 and a 52-week high of $254.00.

Institutional Investors Weigh In On STERIS

Large investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of STERIS during the 4th quarter worth about $220,954,000. Impax Asset Management Group plc lifted its position in STERIS by 419.1% during the fourth quarter. Impax Asset Management Group plc now owns 964,935 shares of the medical equipment provider’s stock worth $211,430,000 after acquiring an additional 779,038 shares during the last quarter. APG Asset Management US Inc. bought a new stake in shares of STERIS during the fourth quarter worth approximately $74,963,000. Goldman Sachs Group Inc. grew its position in shares of STERIS by 71.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 603,879 shares of the medical equipment provider’s stock valued at $132,763,000 after purchasing an additional 252,200 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in shares of STERIS by 58.4% during the third quarter. Envestnet Asset Management Inc. now owns 586,380 shares of the medical equipment provider’s stock worth $128,663,000 after purchasing an additional 216,113 shares during the period. Institutional investors own 94.69% of the company’s stock.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be paid a dividend of $0.52 per share. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 annualized dividend and a dividend yield of 0.98%. STERIS’s dividend payout ratio is currently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.